Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Modern Rheumatology Case Reports|August 15, 2020
Asymptomatic coronary aneurysms in a patient with eosinophilic granulomatosis with polyangiitis who developed a digital gangreneMayu Sato, Yusuke Yoshida, Tomohiro Sugimoto, et al.
Journal of Clinical Medicine|October 9, 2019
Multiple External Root Resorption of Teeth as a New Manifestation of Systemic Sclerosis-A Cross-Sectional Study in JapanTakumi Memida, Shinji Matsuda, Mikihito Kajiya, et al.
Pulmonary Pharmacology & Therapeutics|February 11, 2021
Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort studyToshihito Otani, Kakuhiro Yamaguchi, Shinjiro Sakamoto, et al.
Inflammation and Regeneration|January 7, 2023
Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signalingHirofumi Watanabe, Sho Mokuda, Tadahiro Tokunaga, et al.
Modern Rheumatology|March 29, 2021
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoidsYusuke Yoshida, Tomohiro Sugimoto, Yohei Hosokawa, et al.
Arthritis Research & Therapy|October 28, 2018
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositisYuichi Ishikawa, Shigeru Iwata, Kentaro Hanami, et al.
Modern Rheumatology|September 8, 2011
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)Tsutomu Takeuchi, Yoshiya Tanaka, Yuko Kaneko, et al.
Annals of the Rheumatic Diseases|February 28, 2026
Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial)Yuki Imai, Michihito Kono, Tomonori Ishii, et al.
The Journal of Rheumatology|September 15, 2023
Long-Term Prognosis of Antimelanoma Differentiation-Associated Gene 5-Positive Dermatomyositis With Interstitial Lung DiseaseTsuneo Sasai, Ran Nakashima, Hideaki Tsuji, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 23, 2021
Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case reportToshihito Otani, Hiroshi Iwamoto, Yusuke Yoshida, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Modern Rheumatology Case Reports|August 15, 2020
Asymptomatic coronary aneurysms in a patient with eosinophilic granulomatosis with polyangiitis who developed a digital gangreneMayu Sato, Yusuke Yoshida, Tomohiro Sugimoto, et al.
Journal of Clinical Medicine|October 9, 2019
Multiple External Root Resorption of Teeth as a New Manifestation of Systemic Sclerosis-A Cross-Sectional Study in JapanTakumi Memida, Shinji Matsuda, Mikihito Kajiya, et al.
Pulmonary Pharmacology & Therapeutics|February 11, 2021
Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort studyToshihito Otani, Kakuhiro Yamaguchi, Shinjiro Sakamoto, et al.
Inflammation and Regeneration|January 7, 2023
Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signalingHirofumi Watanabe, Sho Mokuda, Tadahiro Tokunaga, et al.
Modern Rheumatology|March 29, 2021
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoidsYusuke Yoshida, Tomohiro Sugimoto, Yohei Hosokawa, et al.
Arthritis Research & Therapy|October 28, 2018
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositisYuichi Ishikawa, Shigeru Iwata, Kentaro Hanami, et al.
Modern Rheumatology|September 8, 2011
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)Tsutomu Takeuchi, Yoshiya Tanaka, Yuko Kaneko, et al.
Annals of the Rheumatic Diseases|February 28, 2026
Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial)Yuki Imai, Michihito Kono, Tomonori Ishii, et al.
The Journal of Rheumatology|September 15, 2023
Long-Term Prognosis of Antimelanoma Differentiation-Associated Gene 5-Positive Dermatomyositis With Interstitial Lung DiseaseTsuneo Sasai, Ran Nakashima, Hideaki Tsuji, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 23, 2021
Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case reportToshihito Otani, Hiroshi Iwamoto, Yusuke Yoshida, et al.
Pageof 16